Heterogeneity of Multiple System Atrophy: An Update

Area of Science:

• Neurodegenerative diseases
• α-synucleinopathies
• Neuropathology

Background:

• Multiple system atrophy (MSA) is a fatal, rapidly progressing neurodegenerative disorder of unknown cause.
• It is characterized by parkinsonism, cerebellar, autonomic, and motor dysfunctions.
• The hallmark is α-synuclein deposition in glia (glial cytoplasmic inclusions) and neurons, leading to glioneuronal degeneration.

Purpose of the Study:

• To highlight the diagnostic challenges posed by atypical variants of MSA.
• To emphasize the need for revising current diagnostic criteria.
• To underscore the importance of accurate diagnosis for developing disease-modifying treatments.

Main Methods:

• Review of clinical and pathological features of MSA.
• Analysis of diagnostic challenges and differential diagnosis.
• Consideration of atypical variants and their impact on classification.

Main Results:

• MSA presents with a broader spectrum of clinical and pathological features than previously recognized.
• Atypical variants include prodromal forms, mixed MSA, and those with cognitive impairment or unusual pathologies.
• Distinguishing MSA from similar disorders remains challenging despite improved biomarkers.

Conclusions:

• Current MSA classification struggles to accommodate the wide range of atypical variants.
• Revising diagnostic criteria is essential to improve diagnostic accuracy and differential diagnosis.
• Accurate diagnosis is critical for advancing therapeutic strategies for MSA.